Pilot study of a portable vision field machine
Treatments studied
Part of Eyes & vision clinical trials.
This pilot study tests a new portable device for measuring your field of vision during a glaucoma clinic visit. You may benefit from a quicker or more convenient test.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have glaucoma and are visiting the glaucoma clinic.
- Your doctor has planned a 'SITA-STANDARD' visual field test for you.
- You are able to give your own permission to join the study.
- You can sit still, see well enough, and follow instructions to do the test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different ways to measure how glaucoma affects your vision over time by comparing visual field results. It may help researchers find better models to track progression so treatment decisions can be made more accurately.
This trial compares different visual field test patterns to detect central vision loss in glaucoma patients who already show thinning of retinal cells. The goal is to find which test pattern works best for early detection.
This trial tests if a large language model tool can help patients perform more reliable visual field tests. It may improve detection of glaucoma progression.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This study uses advanced eye scans to compare the eyes of people with glaucoma against those with healthy eyes. It aims to find better ways to detect and monitor glaucoma, which could help preserve vision.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.